Načítá se...
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Mounting evidence suggests that immunotherapies are a promising new class of anticancer therapies. However, the immunosuppressive tumor microenvironment (TME), poor immunogenicity, and off-target toxicity hinder the broader implementation of immunotherapies. Here, we describe a novel strategy combin...
Uloženo v:
| Vydáno v: | Sci Adv |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Association for the Advancement of Science
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7455183/ https://ncbi.nlm.nih.gov/pubmed/32923651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abc3646 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|